Identification of Mechanisms by which Insulin Receptor Substrates (IRS) Regulate Cardiomyocyte Metabolism and Survival

胰岛素受体底物 (IRS) 调节心肌细胞代谢和存活的机制的鉴定

基本信息

项目摘要

Clinical trials of tight metabolic control in subjects with type 2 diabetes, which involve intensive insulin therapy increased mortality and the number of major cardiovascular events. We have previously shown in a model of pressure overload that hyperinsulinemia per se activates the insulin signaling cascade in the heart and thereby accelerates cell death and heart failure. Insulin and IGF-1 signaling is mediated by insulin receptor substrates (IRS) 1 and 2. Our preliminary studies identified an IRS-isoform specific contribution to cardiac metabolism and growth. In the presence of pressure overload, IRS1-deletion had beneficial effects whereas absence of IRS2 was detrimental. The underlying mechanisms will to be elucidated in this proposal. Furthermore, while mice with cardiomyocyte-specific deletion of either IRS1 or IRS2 had normal survival, knockdown of both IRS isoforms resulted in increased mortality due to heart failure. Similarly, mice with a combined cardiomyocyte-specific deletion of both insulin (IR) and IGF-1 receptors died from heart failure. In addition to IR and IGF-1 receptors, IRS proteins are linked to cytokine receptors and integrins. Therefore, we propose to investigate IR/IGF-1 receptor dependent and independent mechanisms that contribute to heart failure in IRS1/2-deficient hearts. Together, these studies will provide new insight into the IRS isoform-specific modulation of insulin signaling under conditions of pressure overload and dissect the upstream signals that are transduced by IRS1 and IRS2 in cardiomyocytes.
在2型糖尿病受试者中进行严格代谢控制的临床试验,其中包括强化胰岛素治疗,增加了死亡率和主要心血管事件的数量。我们先前已经在压力超负荷模型中表明,高胰岛素血症本身激活心脏中的胰岛素信号级联,从而加速细胞死亡和心力衰竭。胰岛素和IGF-1信号由胰岛素受体底物(IRS)1和2介导。我们的初步研究确定了IRS-亚型对心脏代谢和生长的特异性贡献。在压力超负荷的存在下,IRS 1缺失具有有益的效果,而IRS 2缺失则是有害的。本提案将阐明基本机制。此外,虽然IRS 1或IRS 2心肌细胞特异性缺失的小鼠具有正常的存活率,但两种IRS亚型的敲低导致心力衰竭导致的死亡率增加。类似地,胰岛素(IR)和IGF-1受体联合心肌细胞特异性缺失的小鼠死于心力衰竭。除了IR和IGF-1受体外,IRS蛋白还与细胞因子受体和整合素连接。因此,我们建议调查IR/IGF-1受体依赖性和非依赖性的机制,有助于在IRS 1/2缺陷的心脏心力衰竭。总之,这些研究将提供新的见解IRS异构体特异性调节胰岛素信号的条件下的压力超负荷和解剖的上游信号转导的IRS 1和IRS 2在心肌细胞。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Enhanced Cardiac Akt/Protein Kinase B Signaling Contributes to Pathological Cardiac Hypertrophy in Part by Impairing Mitochondrial Function via Transcriptional Repression of Mitochondrion-Targeted Nuclear Genes
  • DOI:
    10.1128/mcb.01109-14
  • 发表时间:
    2014-12
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    A. Wende;Brian T. O’Neill;H. Bugger;C. Riehle;Joseph Tuinei;J. Buchanan;Kensuke Tsushima;Li Wang-
  • 通讯作者:
    A. Wende;Brian T. O’Neill;H. Bugger;C. Riehle;Joseph Tuinei;J. Buchanan;Kensuke Tsushima;Li Wang-
Insulin regulation of myocardial autophagy.
Insulin Receptor Substrates Are Essential for the Bioenergetic and Hypertrophic Response of the Heart to Exercise Training
胰岛素受体底物对于心脏对运动训练的生物能和肥厚反应至关重要
  • DOI:
    10.1128/mcb.00426-14
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Riehle C;Wende AR;Oliveira KJ;Pereira RO;Jaishy BP;Bevins J;Valdez S;Kim BJ;Moreira AB;Weatherford ET;Manivel R;Rawlings TA;Rech M;White MF;Abel ED
  • 通讯作者:
    Abel ED
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dr. Christian Riehle其他文献

Dr. Christian Riehle的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dr. Christian Riehle', 18)}}的其他基金

The Impact of Lrat on Cardiomyocyte Energetics and Survival
Lrat 对心肌细胞能量和存活的影响
  • 批准号:
    414169410
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Research Grants
The Impact of Rhot1 and 2 on Cardiomyocyte Energetics and Survival
Rhot1 和 2 对心肌细胞能量和存活的影响
  • 批准号:
    469360875
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似国自然基金

Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国学者研究基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国学者研究基金项目

相似海外基金

IDENTIFYING MICROBIAL MECHANISMS THAT REGULATE ANIMAL INSULIN SIGNALING
识别调节动物胰岛素信号传导的微生物机制
  • 批准号:
    10680954
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Exploring inter-organ crosstalk to uncover mechanisms that regulate islet function under insulin resistance or obesity
探索器官间串扰以揭示胰岛素抵抗或肥胖下调节胰岛功能的机制
  • 批准号:
    23H03324
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidating the pathophysiology and molecular mechanisms of renal insulin resistance
阐明肾胰岛素抵抗的病理生理学和分子机制
  • 批准号:
    10590598
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Mechanisms of Somatostatin-Mediated Inhibition of Insulin and Glucagon
生长抑素介导的胰岛素和胰高血糖素抑制机制
  • 批准号:
    10537377
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Mechanisms of Somatostatin-Mediated Inhibition of Insulin and Glucagon
生长抑素介导的胰岛素和胰高血糖素抑制机制
  • 批准号:
    10642738
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Understanding biological mechanisms influencing feed efficiency in beef cattle: insulin resistance
了解影响肉牛饲料效率的生物机制:胰岛素抵抗
  • 批准号:
    RGPIN-2018-04217
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
The cellular molecular regulation of differing mechanisms of insulin resistance.
胰岛素抵抗不同机制的细胞分子调节。
  • 批准号:
    10531044
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
The cellular molecular regulation of differing mechanisms of insulin resistance.
胰岛素抵抗不同机制的细胞分子调节。
  • 批准号:
    10661826
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
The Mechanisms of Selective Insulin Resistance for the development of Anti-Atherosclerotic Drugs
选择性胰岛素抵抗的机制及其抗动脉粥样硬化药物的开发
  • 批准号:
    22K08640
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathogenic mechanisms of slowly progressive insulin-dependent (type 1) diabetes mellitus
缓慢进展的胰岛素依赖型(1 型)糖尿病的发病机制
  • 批准号:
    22K11779
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了